Cargando…

Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer

Radiotherapy plays an essential role in the treatment of head and neck squamous cell carcinoma (HNSCC), yet radioresistance remains a major barrier to therapeutic efficacy. A better understanding of the predominant pathways determining radiotherapy response could help develop mechanism-informed ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lang, Liwei, Chen, Fanghui, Li, Yamin, Shay, Chloe, Yang, Fan, Dan, Hancai, Chen, Zhuo G., Saba, Nabil F., Teng, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114932/ https://www.ncbi.nlm.nih.gov/pubmed/37089864 http://dx.doi.org/10.1158/2767-9764.CRC-22-0289

Ejemplares similares

Identification of PLXDC1 and PLXDC2 as the transmembrane receptors for the multifunctional factor PEDF
por: Cheng, Guo, et al.
Publicado: (2014)

Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib
por: Lang, Liwei, et al.
Publicado: (2020)

Plxdc2 Is a Mitogen for Neural Progenitors
por: Miller-Delaney, Suzanne F. C., et al.
Publicado: (2011)

The Upregulation of PLXDC2 Correlates with Immune Microenvironment Characteristics and Predicts Prognosis in Gastric Cancer
por: Li, Yang, et al.
Publicado: (2021)

PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer
por: Li, Xinwei, et al.
Publicado: (2022)

Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis
por: He, Leilei, et al.
Publicado: (2019)

Plxdc family members are novel receptors for the rhesus monkey rhadinovirus (RRV)
por: Großkopf, Anna K., et al.
Publicado: (2021)

Overexpression of PLXDC2 in Stromal Cell-Associated M2 Macrophages Is Related to EMT and the Progression of Gastric Cancer
por: Guan, Yiming, et al.
Publicado: (2021)

Glioblastoma endothelium drives bevacizumab‐induced infiltrative growth via modulation of PLXDC1
por: Falchetti, Maria Laura, et al.
Publicado: (2018)

Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics
por: Lang, Liwei, et al.
Publicado: (2017)

Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer
por: Lang, Liwei, et al.
Publicado: (2021)

PLXDC2 enhances invadopodium formation to promote invasion and metastasis of gastric cancer cells via interacting with PTP1B
por: Wu, Bin, et al.
Publicado: (2022)

FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis
por: Lang, Liwei, et al.
Publicado: (2021)

ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development
por: Lang, Liwei, et al.
Publicado: (2022)

Downregulation of miR-1 in colorectal cancer promotes radioresistance and aggressive phenotypes
por: Wu, Yong, et al.
Publicado: (2020)

HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer
por: Mariani, Marisa, et al.
Publicado: (2014)

Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States
por: Yang, Fan, et al.
Publicado: (2023)

Upregulation of Long Noncoding RNA MALAT1 in Colorectal Cancer Promotes Radioresistance and Aggressive Malignance
por: Shen, Wenqi, et al.
Publicado: (2022)

Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer
por: Su, Yong-Han, et al.
Publicado: (2023)

Treatment of Radioresistant Cancers
por: Hendry, J. H.
Publicado: (1980)

Exosomes in Cancer Radioresistance
por: Ni, Jie, et al.
Publicado: (2019)

Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
por: Lang, Liwei, et al.
Publicado: (2018)

SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer
por: Jin, Yuxiao, et al.
Publicado: (2021)

The diverse functions of FAT1 in cancer progression: good, bad, or ugly?
por: Chen, Zhuo Georgia, et al.
Publicado: (2022)

STAT3 Contributes to Radioresistance in Cancer
por: Wang, Xuehai, et al.
Publicado: (2020)

Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells
por: Kang, JiHoon, et al.
Publicado: (2016)

Drivers of Radioresistance in Prostate Cancer
por: King, Liam, et al.
Publicado: (2022)

Plexin domain containing 2 (PLXDC2) gene polymorphism rs7081455 may not influence POAG risk in a Saudi cohort
por: Kondkar, Altaf A., et al.
Publicado: (2018)

mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes
por: Luo, Judong, et al.
Publicado: (2017)

Triple‑negative breast cancer cells that survive ionizing radiation exhibit an Axl‑dependent aggressive radioresistant phenotype
por: Ji, Jianfeng, et al.
Publicado: (2023)

Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
por: Kim, Ga Hee, et al.
Publicado: (2018)

Targeting HMGB3/hTERT axis for radioresistance in cervical cancer
por: Li, Zongjuan, et al.
Publicado: (2020)

Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma
por: Lang, Liwei, et al.
Publicado: (2019)

Nck-associated protein 1 associates with HSP90 to drive metastasis in human non-small-cell lung cancer
por: Xiong, Yuanping, et al.
Publicado: (2019)

Transcription factor ATF3 mediates the radioresistance of breast cancer
por: Zhao, Wenyan, et al.
Publicado: (2018)

Survivin as a Radioresistance Factor in Pancreatic Cancer
por: Asanuma, Koichi, et al.
Publicado: (2000)

Cancer stem cells and signaling pathways in radioresistance
por: Chang, Lei, et al.
Publicado: (2015)

Epigenetic mechanisms underlying prostate cancer radioresistance
por: Macedo-Silva, Catarina, et al.
Publicado: (2021)

Energy Metabolism Is Altered in Radioresistant Rectal Cancer
por: Buckley, Croí E., et al.
Publicado: (2023)

Role of Met Axis in Head and Neck Cancer
por: Xu, Yiru, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_67c60ah5b77cpnatvk833orkso